title: Pemphigus in South Africa.
abstract: BACKGROUND
  Pemphigus is an autoimmune disease characterized by intraepidermal blistering. We describe the demography, prevalence, clinical features, response to treatment, and human leukocyte antigen (HLA) characteristics of pemphigus in Kwa-Zulu Natal, South Africa.
  
  
  METHODS
  All patients with pemphigus were prospectively recruited over 12 years from January 1987 to December 1999. The demography, clinical features, histology, and immunofluorescence (IF) were recorded. In a subset of patients, HLA tests were performed.
  
  
  RESULTS
  One hundred and twelve patients had pemphigus. Pemphigus foliaceus (PF) was the commonest variant seen (62 patients) and 80% of these patients were black. The mean age was 43 years (12-93 years) and the male to female ratio was 1 : 1.4. Fifty patients had pemphigus vulgaris (PV), of whom 82% were Indian. The mean age of presentation of PV was 48 years (21-82 years). The male to female ratio was 1 : 1.7. There was no mucosal involvement in PF. PV patients had painful oral lesions. The mortality rate was 14% in the total sample (six in PV and two in PF). HLA-B8 was positive in 41% of patients with PF (P < 0.001).
  
  
  CONCLUSIONS
  PF occurs more commonly in black people, while most cases in Indians present with the PV subtype. Pemphigus patients present with severe and extensive disease, and PV patients share features in common with patients from their land of origin (India), suggesting a genetic link.
authors.affiliation: Dermatology Department and Anatomical Pathology, Faculty of Medicine, University of Natal and King Edward VIII Hospital, Congella, South Africa.
authors.forename: J
authors.initials: J
authors.lastname: Aboobaker
authors.forename: N
authors.initials: N
authors.lastname: Morar
authors.forename: P K
authors.initials: PK
authors.lastname: Ramdial
authors.forename: M G
authors.initials: MG
authors.lastname: Hammond
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D044383:Black People; D003710:Demography; D005260:Female; D005455:Fluorescent Antibody Technique; D006680:HLA Antigens; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007194:India / Q000208:ethnology; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D015995:Prevalence; D011446:Prospective Studies; D013019:South Africa / Q000453:epidemiology; D013256:Steroids; D044465:White People
chemical_list: D000893:Anti-Inflammatory Agents; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D013256:Steroids